icad's average Accounts Receivable for the
three
months ended in Dec. 2023 was $5.63 Mil. icad's Revenue for the
three
months ended in Dec. 2023 was $4.74 Mil.
Hence, icad's Days Sales Outstanding for the
three
months ended in Dec. 2023 was 108.35.
The historical rank and industry rank for icad's Days Sales Outstanding or its related term are showing as below:
ICAD'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 71.73 Med: 98.55 Max: 135.11
Current: 107.61
During the past 13 years, icad's highest Days Sales Outstanding was 135.11. The lowest was 71.73. And the median was 98.55.
ICAD's Days Sales Outstanding is ranked worse than 81.91% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 63.94
vs ICAD: 107.61
icad's Days Sales Outstanding
declined
from Dec. 2022 (140.18) to Dec. 2023 (108.35).
icad Days Sales Outstanding Historical Data
The historical data trend for icad's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of icad's Days Sales Outstanding
For the Medical Devices subindustry, icad's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
icad's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, icad's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where icad's Days Sales Outstanding falls into.
icad Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
icad (NAS:ICAD) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
icad Days Sales Outstanding Related Terms
Thank you for viewing the detailed overview of icad's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company reports in two segments: Detection and Therapy. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. In the Therapy segment, the Company offers the Xoft System, an isotope-free cancer treatment platform technology. The Xoft System can be used for the treatment of early-stage breast cancer, endometrial cancer, cervical cancer and nonmelanoma skin cancer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ICAD has been successfully added to your 